कंपनी का अवलोकन
BIO-key International, Inc. is primarily engaged in the development and marketing of fingerprint identification biometric technology and software solutions, alongside enterprise-ready identity access management solutions designed for commercial, government, and education sectors within the United States and internationally. The company operates within the Industrials sector, specifically focusing on the Security & Protection Services industry, a classification that highlights its role in safeguarding digital identities and physical access points across diverse organizational structures. Its current market capitalization stands at $6.08M, with an annual revenue of $6.10M, while specific employee count data is not publicly disclosed in the available records. These valuation and revenue figures indicate that BIO-key operates as a micro-cap entity with a modest financial footprint, suggesting limited scale relative to larger industrial peers and potentially exposing the firm to higher volatility associated with smaller market capitalizations.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $6.10M, yet it simultaneously recorded a net income of $-4,590,370 and an EBITDA of $-3,908,300, revealing a significant divergence between top-line generation and bottom-line profitability. This substantial gap between revenue and net income indicates a cost structure where operating expenses and losses heavily outweigh the gross earnings generated from sales, resulting in a net loss that exceeds the gross profit. Furthermore, the free cash flow stands at $-2,806,292, which signifies a consumption of cash rather than generation, implying that the company currently lacks the financial flexibility to fund expansion or debt repayment through internal cash flows without external financing. Analyzing the margins, the gross margin is robust at 77.5%, suggesting high pricing power or low cost of goods sold, whereas the operating margin is critically negative at -132.4% and the profit margin is -75.3%, indicating that operating expenses are so elevated they consume the entire gross profit and then some, leading to a loss on every dollar of revenue. Regarding liquidity and leverage, the company holds $2.69M in cash against $703,626 in debt, resulting in a debt-to-equity ratio of 9.18, which suggests a highly leveraged balance sheet structure where debt obligations are significant relative to equity, although the cash position provides a buffer. The current ratio is 1.49, which indicates that the company possesses sufficient current assets to cover its short-term liabilities, pointing to a manageable level of short-term liquidity despite the ongoing operational losses. Additionally, the return on equity is -80.2% and the return on assets is -27.3%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate positive returns, a common characteristic of early-stage or turnaround-oriented companies in the security sector.
मूल्यांकन आकलन
The valuation metrics present a complex picture, as the P/E Ratio (TTM) is listed as N/A and the Forward P/E is inf, a disparity that implies earnings are currently negative and no future earnings per share are expected to justify the stock price under traditional multiple analysis. The price-to-book ratio stands at 0.79, indicating that the market values the company at less than its net asset book value, which often suggests that investors perceive significant risks or that the company's intangible assets and future growth potential are not fully captured on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 1.00 and an EV/EBITDA of -1.05, suggesting that the stock is priced at one dollar of sales but the enterprise value relative to earnings is negative due to the lack of profitability. In terms of price action, the 52-week high is $1.97 and the 52-week low is $0.49; without a specific current share price provided in the facts, the valuation range indicates a stock that has experienced significant volatility within this specific band over the last year. The beta value is 0.50, which means the stock's price volatility is roughly half that of the broader market, suggesting it may be less sensitive to general market movements but still subject to sector-specific risks inherent in the security services industry.
Growth & Income
The company is experiencing a contraction in top-line growth with a revenue growth rate of -15.1% year-over-year, while earnings growth is listed as N/A due to the lack of profitability, implying that the business is currently in a decline phase rather than a growth phase. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it is not returning cash to shareholders but is instead retaining all earnings (which are negative) and relying on its cash reserves to sustain operations. This non-dividend profile indicates that the company reinvests its limited resources, or rather its cash holdings, into growth initiatives or operational restructuring rather than providing income to investors, a strategy typical of firms attempting to reverse negative trends. Overall, the growth and income profile for BIO-key International, Inc. is characterized by negative revenue momentum, a complete absence of income distribution, and a reliance on balance sheet strength to navigate a period of financial contraction and operational unprofitability.